Podcast Index
Browse podcasts by category, open recent episodes, and download audio to listen offline.
Decera Clinical Education Oncology Podcast
Decera Clinical Education
Neville Goddard Daily
Neville Goddard
Daily Short Stories - Ghost and Horror Stories
Sol Good Network
Daily Science Fiction Stories
solgoodmedia.com
Science Fiction - Daily Short Stories
Sol Good Network
Stories - Science Fiction
Sol Good Network
Daily Ghost and Horror Stories
solgoodmedia.com
SciFi Cast
solgoodmedia.com
Mind Webs Radio
solgoodmedia.com
Quiet Please
Wyllis Cooper
Mind Webs
solgoodmedia.com
The Adventures of Superman
Dashiell Hammett
Classic Radio Science Fiction
solgoodmedia.com
Science Fiction Radio Hour
solgoodmedia.com
Interstellar Sci-Fi Tunes
solgoodmedia.com
Time Traveler's Radio
solgoodmedia.com
Science Fiction Radio
solgoodmedia.com
Timeless Sci-Fi Radio
solgoodmedia.com
Old Time Science Fiction
solgoodmedia.com
Galactic Sci-Fi Broadcasts
solgoodmedia.com
Pioneer Sci-Fi Radio
solgoodmedia.com
Future Worlds Radio
solgoodmedia.com
Vintage Sci-Fi Radio
solgoodmedia.com
Classic Radio Science Fiction
solgoodmedia.com
Daily Short Stories - Science Fiction
Public Domain Books
Mind Webs - Old Time Audio
Michael Hanson
Thunderstorm Ambience
Sol Good Media
Bedtime Astronomy
Synthetic Universe
Consider Before Consuming
Fight the New Drug
New York City Weather Today - forecast for NYC
Caloroga Labs New York City
Understand All
Aaron Barlow
East Pass Podcast
East Pass Podcast
Systemrelevant - Fakten für eine demokratische und nachhaltige Wirtschaft
Hans-Böckler-Stiftung
Farm Food Facts
USFRA
Eye On The Sky
Vermont Public
The Poison Lab
Clinical Toxicology LLC
Answers with Ken Ham
Ken Ham and Mark Looy
Science
Decera Clinical Education
Listen in to learn from Cristina Saura Manich, MD, PhD and Giampaolo Bianchini, MD about practical approaches to PI3K pathway testing, PI3K/AKT-targeted treatment options, and endocrine-based sequencing in metastatic bre...
Link to claim CME credit: https://bit.ly/4uRr3ir In this episode, Elizabeth Krueger, NP, and Sam Vafadar, DHSc, PA-C, discuss how they optimize first-line EGFR-targeted therapy for patients with EGFR-mutated NSCLC, inclu...
In this episode, Dr Abbie Begnaud discusses the importance of lung cancer screening and evolving strategies to improve early detection among high-risk populations, including: Low-dose CT screening, which reduces lung c...
In this episode, Aarti Bhatia, MD, MPH, and Deborah J. Wong, MD, PhD, discuss the rapidly evolving treatment landscape for recurrent, metastatic, and locally advanced head and neck squamous cell carcinoma (HNSCC), incl...
In this episode, hear Doris K. Hansen, MD, discuss the management of relapsed/refractory multiple myeloma with bispecific antibodies including: Practical differences among approved bispecific antibodies Toxicity profi...
In this episode, Muhamed Baljevic, MD, FACP, and Johnathan Ticku, MD, discuss various strategies to optimize the use of bispecific antibodies in their practices for the treatment of R/R MM through patient monitoring, dos...
In this episode, hear Anthony Hunter, MD and Douglas Tremblay, MD discuss the various presentations of thrombotic events in patients with PV or ET including how thrombotic events may lead to diagnosis: PV and ET incre...
In this podcast episode, Ciro Rinaldi MD, PhD, and Alessandro M. Vannucchi, MD, discuss contemporary management of essential thrombocythemia (ET) and polycythemia vera (PV), as well as novel investigational approaches, i...
In this podcast episode, Ciro Rinaldi, MD, PhD, and Alessandro M. Vannucchi, MD, as they discuss contemporary topics in diagnosing essential thrombocythemia (ET) and polycythemia vera (PV), including: Overview of diagn...
In this podcast episode, Erika Hamilton, MD, FASCO, and Ian Krop, MD, PhD, discuss recent developments in the field of first-line therapy and maintenance treatment for patients with HER2-positive metastatic breast cancer...
A patient advocate/cancer survivor and a healthcare professional discuss key topics including early breast cancer diagnosis, role of self-agency in pursuing optimal cancer care, encouraging trial participation with patie...
Podcast with global experts discussing the role of AKT and PI3K inhibitors in patients with resistance to endocrine therapy in the adjuvant or metastatic disease settings following current guidelines, indications, and be...
In this episode, Danielle Roman, PharmD, BCOP, and Jordan Hill, PharmD, BCOP, discuss patient-centered management of CDK4/6 inhibitor therapy in HR-positive/HER2-negative breast cancer, with a focus on how oncology pharm...
In this episode, Dr Matthew Gubens and Dr Helena Yu discuss the evolving role of TROP2-directed therapies in non-small-cell lung cancer, with a focus on how antibody–drug conjugates (ADCs) fit into current treatment stra...
In this podcast episode, Amit Mahipal, MD, MPH, and Shubham Pant, MD, discuss new and emerging therapies for the individualized care of patients with HER2-positive gastroesophageal adenocarcinoma and biliary tract cancer...
In this podcast episode, Aditya Bardia, MD, MPH, FASCO, and Ruta Rao, MD, discuss ADCs for HER2-negative/ultralow/low metastatic breast cancer, including: Classifying HER2 expression in MBC today (HER2 negative/ultralo...
Advanced practice providers discuss biomarker testing in patients with colorectal cancer. Listen in to learn from Ann Marie Siney, RN, MSN, ANP-BC, and Kathleen Boyle, DScPAS, PA-C, about familial cancer syndromes associ...
Listen to this audio podcast covering biomarker testing in patients with prostate cancer. Learn from Sara Traverso, MMS, PA-C, and Brenda Martone, MSN, ANP-BC, AOCNP, about when to conduct germline and somatic genetic te...
In this episode, Sam S. Chang, MD, MBA, and Matthew D. Galsky, MD, discuss the rapidly evolving treatment landscape in bladder cancer, highlighting new therapeutic options, emerging clinical trial data, including the lat...
In this episode, oncology pharmacists Julia L. Ziegengeist, PharmD, BCOP, and Rodney Hunter, PharmD, BCOP, explore and challenge common assumptions about adjuvant CDK4/6 inhibitor use in high-risk HR+/HER2- early breast ...
Fill in the form below. Make sure to select both Country and Genres.
Send us a message below. We will get back to you within 24 hours.